Literature DB >> 15136506

Chronic hyperglycemia attenuates coronary collateral development and impairs proliferative properties of myocardial interstitial fluid by production of angiostatin.

Dorothee Weihrauch1, Nicole L Lohr, Boris Mraovic, Lynda M Ludwig, William M Chilian, Paul S Pagel, David C Warltier, Judy R Kersten.   

Abstract

BACKGROUND: Development of coronary collateral vessels is impaired in patients with diabetes mellitus. We tested the hypothesis that hyperglycemia alone attenuates collateral development and abolishes proliferative properties of myocardial interstitial fluid (MIF) by enhancing expression of matrix metalloproteinases (MMP) and angiostatin. METHODS AND
RESULTS: Chronically instrumented dogs were randomly assigned to receive an infusion of normal saline (control; n=9) or 70% dextrose in water to increase blood glucose to 350 to 400 mg/dL for 8 h/d (hyperglycemia; n=7) in the presence or absence (sham; n=9) of brief (2 minutes), repetitive coronary artery occlusions (1/h; 8/d for 21 days). Collateral perfusion increased to 41+/-11% and 49+/-6% of normal zone flow in control dogs on days 14 and 21 (P<0.05) but remained unchanged over 21 days in hyperglycemic and sham dogs (12+/-3% and 13+/-3%, respectively). A progressive reduction of the postocclusive peak reactive hyperemic response was also observed in control dogs (16+/-1 to 10+/-1 Hz. 10(2) on days 1 and 21, respectively) but not in hyperglycemic (17+/-2 to 20+/-2) or sham (17+/-2 to 16+/-1) dogs. Endothelial cell tube formation was produced by MIF obtained from control dogs but not hyperglycemic or sham dogs. Coincubation of MIF from hyperglycemic dogs with an angiostatin antibody restored endothelial cell tube formation. MMP-9 activity and expression of angiostatin were increased in dogs receiving exogenous glucose compared with controls
CONCLUSIONS: Chronic hyperglycemia abolishes development of coronary collateral vessels by increasing MMP-9 activity and angiostatin expression in dogs.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15136506     DOI: 10.1161/01.CIR.0000129225.67353.1F

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  27 in total

1.  Angiopoietin/Tie2 pathway mediates type 2 diabetes induced vascular damage after cerebral stroke.

Authors:  Xu Cui; Michael Chopp; Alex Zacharek; Xinchun Ye; Cynthia Roberts; Jieli Chen
Journal:  Neurobiol Dis       Date:  2011-04-16       Impact factor: 5.996

Review 2.  Redox-dependent mechanisms in coronary collateral growth: the "redox window" hypothesis.

Authors:  June Yun; Petra Rocic; Yuh Fen Pung; Souad Belmadani; Ana Catarina Ribeiro Carrao; Vahagn Ohanyan; William M Chilian
Journal:  Antioxid Redox Signal       Date:  2009-08       Impact factor: 8.401

Review 3.  Why is coronary collateral growth impaired in type II diabetes and the metabolic syndrome?

Authors:  Petra Rocic
Journal:  Vascul Pharmacol       Date:  2012-02-09       Impact factor: 5.773

4.  Acute Phase Hyperglycemia among Patients Hospitalized with Acute Coronary Syndrome: Prevalence and Prognostic Significance.

Authors:  Abbas Ali Mansour; Hameed Laftah Wanoose
Journal:  Oman Med J       Date:  2011-03

5.  Endostatin and angiostatin are increased in diabetic patients with coronary artery disease and associated with impaired coronary collateral formation.

Authors:  Neel R Sodha; Richard T Clements; Munir Boodhwani; Shu-Hua Xu; Roger J Laham; Cesario Bianchi; Frank W Sellke
Journal:  Am J Physiol Heart Circ Physiol       Date:  2008-12-12       Impact factor: 4.733

Review 6.  Therapeutic angiogenesis in diabetes and hypercholesterolemia: influence of oxidative stress.

Authors:  Munir Boodhwani; Frank W Sellke
Journal:  Antioxid Redox Signal       Date:  2009-08       Impact factor: 8.401

7.  Longevity is associated with increased vascular resistance to high glucose-induced oxidative stress and inflammatory gene expression in Peromyscus leucopus.

Authors:  Nazar Labinskyy; Partha Mukhopadhyay; Janos Toth; Gabor Szalai; Monika Veres; Gyorgy Losonczy; John T Pinto; Pal Pacher; Praveen Ballabh; Andrej Podlutsky; Steven N Austad; Anna Csiszar; Zoltan Ungvari
Journal:  Am J Physiol Heart Circ Physiol       Date:  2009-01-30       Impact factor: 4.733

8.  Hematological parameters and coronary collateral circulation in patients with stable coronary artery disease.

Authors:  Selim Ayhan; Serkan Ozturk; Alim Erdem; Mehmet Fatih Ozlu; Tolga Memioglu; Mehmet Ozyasar; Mehmet Yazici
Journal:  Exp Clin Cardiol       Date:  2013

9.  Impaired coronary collateral growth in the metabolic syndrome is in part mediated by matrix metalloproteinase 12-dependent production of endostatin and angiostatin.

Authors:  Tracy Dodd; Luke Wiggins; Rebecca Hutcheson; Erika Smith; Alla Musiyenko; Brenda Hysell; James C Russell; Petra Rocic
Journal:  Arterioscler Thromb Vasc Biol       Date:  2013-04-18       Impact factor: 8.311

10.  Insulin treatment enhances the myocardial angiogenic response in diabetes.

Authors:  Munir Boodhwani; Neel R Sodha; Shigetoshi Mieno; Basel Ramlawi; Shu-Hua Xu; Jun Feng; Richard T Clements; Marc Ruel; Frank W Sellke
Journal:  J Thorac Cardiovasc Surg       Date:  2007-11-05       Impact factor: 5.209

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.